For research use only. Not for therapeutic Use.
Gadoteridol is a gadolinium-based magnetic resonance imaging (MRI) contrast agent, used in the imaging of the central nervous system[1].
Gadoteridol (1 mM; intracerebral injection; once) enhances distribution of rAAV1 in the rat hippocampus[1].
| Catalog Number | I000738 |
| CAS Number | 120066-54-8 |
| Synonyms | 2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+) |
| Molecular Formula | C17H28GdN4O7 |
| Purity | ≥95% |
| InChI | InChI=1S/C17H32N4O7.Gd/c1-14(22)10-18-2-4-19(11-15(23)24)6-8-21(13-17(27)28)9-7-20(5-3-18)12-16(25)26;/h14,22H,2-13H2,1H3,(H,23,24)(H,25,26)(H,27,28);/q;+3/p-3 |
| InChIKey | DPNNNPAKRZOSMO-UHFFFAOYSA-K |
| SMILES | CC(CN1CCN(CCN(CCN(CC1)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])O.[Gd+3] |
| Reference | [1]. Hullinger R, et al. The MRI contrast agent gadoteridol enhances distribution of rAAV1 in the rat hippocampus. Gene Ther. 2013 Dec;20(12):1172-7. |
